Reported 5 months ago
Elevance Health has expressed concerns over its Medicaid business for 2024, anticipating increased medical claims due to a shift in patient demographics towards sicker individuals. This has resulted in a nearly 7% drop in its shares, with the company revising its medical loss ratio forecast upwards to account for higher utilization rates in the latter half of the year. Despite these challenges, Elevance reported a profit that exceeded estimates, driven by strong performance in its health services segment.
Source: YAHOO